Anto Biosciences
ActiveAI-nativeA Foundation Model for Microbial Communities.
What it does
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures. Founded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed sparsification) and David (Harvard Medical School Gastroenterology, J&J), second-time founders who published the breakthrough at leading machine learning AI conferences and Nature.
Its site says now · captured 2026-08-23
Anto | A Frontier Biology AI Lab
We are a scientists and second-time founders developing foundation models to make the gut microbiome computable for drug development.
Next to it in Healthcare and bio · Microbiome foundation model for drug discovery
- Ditto BiosciencesY Combinator W26
Evolutionary intelligence for autoimmune disease
- PiramidalY Combinator W24
Foundation Model for the Brain
- Diffuse BioY Combinator W23
Generative AI for protein design
- PaulingPlug and Play PnP 2025
Next-generation molecular simulation platform for drug discovery.
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
- b12 LabsY Combinator S25
Making hard molecules for Pharma and Biotech
- ConvexiaY Combinator S25
The world's first AI-maximalist pharma company
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.